Safety of JAK inhibitors versus other biologic therapies following anti-TNF failure in patients with rheumatoid arthritis.

Arthritis Res Ther · 2025 · PMC12717725 · PMID 41419971

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Among patients who had failed only one TNFi ( n = 152; 96 OMA and 63 JAKi), AEs were numerically more frequent during OMA treatment, although the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.